Search hospitals > California > Palo Alto

Lucile Packard Children's Hospital Stanford University

Claim this profile
Palo Alto, California 94304
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Brain Tumor
Conducts research for Neuroblastoma
418 reported clinical trials
42 medical researchers
Photo of Lucile Packard Children's Hospital Stanford University in Palo AltoPhoto of Lucile Packard Children's Hospital Stanford University in Palo AltoPhoto of Lucile Packard Children's Hospital Stanford University in Palo Alto

Summary

Lucile Packard Children's Hospital Stanford University is a medical facility located in Palo Alto, California. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Brain Tumor, Neuroblastoma and other specialties. Lucile Packard Children's Hospital Stanford University is involved with conducting 418 clinical trials across 714 conditions. There are 42 research doctors associated with this hospital, such as Jay Michael S. Balagtas, Gail L Wright, MD, Sonia Partap, MD, and Norman J. Lacayo, MD.

Area of expertise

1Leukemia
Global Leader
Lucile Packard Children's Hospital Stanford University has run 72 trials for Leukemia. Some of their research focus areas include:
Stage II
Philadelphia chromosome positive
t(8;21)(q22;q22) positive
2Tumors
Global Leader
Lucile Packard Children's Hospital Stanford University has run 54 trials for Tumors. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Lucile Packard Children's Hospital Stanford University

Brain Tumor
Acute Lymphoblastic Leukemia
Rhabdomyosarcoma
Non-Hodgkin's Lymphoma
Medulloblastoma
Diffuse Intrinsic Pontine Glioma
Leukemia
Tumors
Osteosarcoma
Lymphoblastic Leukemia-Lymphoma
Image of trial facility.

Selumetinib vs Carboplatin/Vincristine

for Brain Cancer

This study is evaluating whether a drug which blocks enzymes that tumor cells need for growth may help treat low-grade glioma.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This study is evaluating whether a drug called selumetinib may help treat low-grade glioma.
Recruiting2 awards Phase 3
Image of trial facility.

SurVaxM Vaccine

for Brain Cancer

Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells that express a protein called survivin and destroy them. The survivin protein can be found on up to 95% of glioblastomas and other types of cancer but is not found in normal cells. If the body's immune system knows to destroy cells that express survivin, it may help to control tumor growth and recurrence. SurVaxM will be mixed with Montanide ISA 51 before it is given. Montanide ISA 51 is an ingredient that helps create a stronger immune response in people, which helps the vaccine work better. This study has two phases: Priming and Maintenance. During the Priming Phase, patients will get one dose of SurVaxM combined with Montanide ISA 51 through a subcutaneous injection (a shot under the skin) at the start of the study and every 2 weeks for 6 weeks (for a total of 4 doses). At the same time that patients get the SurVaxM/Montanide ISA 51 injection, they will also get a second subcutaneous injection of a medicine called sargramostim. Sargramostim is given close to the SurVaxM//Montanide ISA 51 injection and works to stimulate the immune system to help the SurVaxM/Montanide ISA 51 work more effectively. If a patient completes the Priming Phase without severe side effects and his or her disease stays the same or improves, he or she can continue to the Maintenance Phase. During the Maintenance Phase, the patient will get a SurVaxM/Montanide ISA 51 dose along with a sargramostim dose about every 8 weeks for up to two years. After a patient finishes the study treatment, the doctor and study team will continue to follow his/her condition and watch for side effects up to 3 years following the last dose of SurVaxM/Montanide ISA 51. Patients will be seen in clinic every 3 months during the follow-up period.
Recruiting1 award Phase 1

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Lucile Packard Children's Hospital Stanford University?
Lucile Packard Children's Hospital Stanford University is a medical facility located in Palo Alto, California. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Brain Tumor, Neuroblastoma and other specialties. Lucile Packard Children's Hospital Stanford University is involved with conducting 418 clinical trials across 714 conditions. There are 42 research doctors associated with this hospital, such as Jay Michael S. Balagtas, Gail L Wright, MD, Sonia Partap, MD, and Norman J. Lacayo, MD.
Where is Lucile Packard Children's Hospital Stanford University located?
Lucile Packard Children's Hospital Stanford is located at 725 Welch Road, Palo Alto, CA 94304. It is part of the Stanford University Medical Center. The main entrance is accessible from Welch Road.
Who should I call to ask about financial aid or insurance network?
**Lucile Packard Children's Hospital Stanford University - Financial Assistance and Insurance Inquiries** **Financial Assistance:** - **Phone:** 844-498-2900 (Monday – Friday, 8:00 a.m. – 5:00 p.m.) - **Mail:** SHC Patient Financial Assistance, Patient Financial Services, P.O. BOX 740715, Los Angeles, CA 90074-0715 **Financial Counseling:** - **Phone:** 650-736-2273 - **Details:** Contact the Financial Counseling Team to discuss financial assistance applications. For additional support, visit the Stanford Medicine Children's Health Financial Assistance Application page.
What insurance does Lucile Packard Children's Hospital Stanford University accept?
Lucile Packard Children's Hospital Stanford University accepts a range of insurance plans, such as Anthem Blue Cross, Medi-Cal Fee For Service, and Blue Shield of California. As part of the Stanford Health Care network, it has agreements with numerous health plans and medical groups. For the most accurate and current information on accepted insurance plans, contact the hospital directly.
What awards or recognition has Lucile Packard Children's Hospital Stanford University received?
Lucile Packard Children's Hospital Stanford is celebrated as one of the 100 great hospitals in the nation by Becker's Hospital Review and has earned Magnet® Recognition for outstanding nursing practice, teamwork, and patient care. It consistently ranks in the top 20 of all children's hospitals by U.S. News & World Report. The hospital is renowned for its excellence in neonatology, nephrology, pulmonology, and endocrinology.